Unique ID issued by UMIN | UMIN000017815 |
---|---|
Receipt number | R000020603 |
Scientific Title | Verification of the preventive effect for vincristin-induced peripheral neuropathy by frozen gloves and socks |
Date of disclosure of the study information | 2015/06/08 |
Last modified on | 2018/12/06 09:11:30 |
Verification of the preventive effect for vincristin-induced peripheral neuropathy by frozen gloves and socks
Verification of the preventive effect for vincristin-induced peripheral neuropathy by frozen gloves and socks
Verification of the preventive effect for vincristin-induced peripheral neuropathy by frozen gloves and socks
Verification of the preventive effect for vincristin-induced peripheral neuropathy by frozen gloves and socks
Japan |
Cancer
Hematology and clinical oncology | Orthopedics | Nursing |
Malignancy
NO
To study the efficacy to prevent vincristin-induced peripheral neuropathy by frozen gloves and socks
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
Incidence of chemotherapy-induced peripheral neuropathy assessed at each cycle
FACT/GOG-NTx(patient questionnaire)
Tolerability of frozen gloves and socks
Skin toxicity
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Device,equipment |
All patients wear frozen glove and socks on either side of hand and foot.
15 | years-old | <= |
Not applicable |
Male and Female
1) Diagnosed as histologically malignant lymphoma receiving (R-) CHOP therapy or (R-) CVP therapy (vincristin administration).
2) Diagnosed as histologically Ewing sarcoma receiving VDC therapy or VAC therapy (vincristin administration).
3) Diagnosed as histologically rhabdomyosarcoma receiving radiation therapy combination VAC (2200) or VAC (1200) therapy or radiation
4) Patients planned to receive chemotherapy in the age over 15 years old of hospitalization or outpatient chemotherapy room.
5) Cases to have agreed to enter this study as participants from the description document.
1) Drug allergy that might interfere with this drug, patients with cold allergy and its history.
2)Patients with any of the grade two or more of peripheral neuropathy or limb edema in the registration time.
3)Patients with metastatic tumor found in (sub)cutaneous lesion.
4) Patients with Raynaud's symptoms, peripheral arterial ischemia symptoms, hand-foot syndrome, or injury in the hands or feet, and patients the doctor has determined inadequate for this study.
5) Patients with demyelinating Charcot-Marie-Tooth disease.
6) Patients with pregnancy or breast-feeding.
10
1st name | |
Middle name | |
Last name | Hirokazu Komatsu |
Nagoya City University Hospital
Division of Chemotherapy
1-Kawasumi, Mizuho-cho,Mizuho-ku, Nagoya
052-851-5511
komatsu@med.nagoya-cu.ac.jp
1st name | |
Middle name | |
Last name | Mayumi Haruta |
Nagoya City University Hospital
Division of Chemotherapy
1-Kawasumi, Mizuho-cho,Mizuho-ku, Nagoya
052-851-5511(7428)
kbkyw108@ybb.ne.jp
Nagoya City University Hospital,Division of Chemotherapy
Kidani Memorial Trust
Non profit foundation
Aichi Nursing Association
NO
名古屋市立大学病院
2015 | Year | 06 | Month | 08 | Day |
Published
Main results already published
2014 | Year | 04 | Month | 02 | Day |
2015 | Year | 06 | Month | 08 | Day |
2017 | Year | 12 | Month | 01 | Day |
2017 | Year | 12 | Month | 01 | Day |
2017 | Year | 12 | Month | 01 | Day |
2017 | Year | 12 | Month | 01 | Day |
2015 | Year | 06 | Month | 04 | Day |
2018 | Year | 12 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020603